Pharmareferent Oncology (m/w/d) Gebiet: 202403 Ulm, Augsburg, München

Germany

Auto‑apply with AI Apply

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Candidates should possess a scientific education (ideally a university degree) or training as a qualified Pharmaceutical Representative (Pharmareferent:in). A minimum of 2 years of professional experience as a Pharmaceutical Representative is required, with in-depth knowledge of the diabetes field and experience in practices and clinics. Strong sales skills and goal-oriented work habits are necessary, along with high social competence, teamwork skills, and networking abilities. Digital IT skills and effective use of modern communication channels for customer-oriented interaction are also required. Furthermore, responsible, independent, and honest conduct is expected, and good English skills (written and spoken) are needed.

Responsibilities

The Pharmareferent Oncology will conduct sales conversations with specialist groups in practices, clinics, and pharmacies, utilizing digital communication channels. They will implement sales and marketing strategies, develop and execute area action plans, and manage contact planning. The role also involves organizing and conducting training events, both in person and digitally, and contributing to the planning and execution of events and workshops.

Skills

Sales

Digital Communication

Event Organization

Pharmaceutical Knowledge

Customer Engagement

Marketing Strategy

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free